Identification of FtfL as a novel target of berberine in intestinal bacteria

Abstract Background Berberine (BBR) is a commonly used anti-intestinal inflammation drug, and its anti-cancer activity has been found recently. BBR can intervene and control malignant colorectal cancer (CRC) through intestinal microbes, but the direct molecular target and related mechanism are uncle...

Full description

Bibliographic Details
Main Authors: Jinci Yan, Chengli Fang, Gaohua Yang, Jianxu Li, Yanqiang Liu, Lu Zhang, Pengjie Yang, Jingyuan Fang, Yang Gu, Yu Zhang, Weihong Jiang
Format: Article
Language:English
Published: BMC 2023-12-01
Series:BMC Biology
Subjects:
Online Access:https://doi.org/10.1186/s12915-023-01778-w